In vivocharacterization of activatable cell penetrating peptides for targeting protease activity in cancer
- 11 May 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 1 (5-6), 382-393
- https://doi.org/10.1039/b904890a
Abstract
Highlights of our enzyme-activatable cell penetrating peptide technology for targeting disease-based processes in cancer, which could have applicability to multThis publication has 33 references indexed in Scilit:
- In vivocharacterization of activatable cell penetrating peptides for targeting protease activity in cancerIntegrative Biology, 2009
- Systemicin vivodistribution of activatable cell penetrating peptides is superior to that of cell penetrating peptidesIntegrative Biology, 2009
- Novel solubility‐switchable MRI agent allows the noninvasive detection of matrix metalloproteinase‐2 activity in vivo in a mouse modelMagnetic Resonance in Medicine, 2008
- Protease‐Triggered Unveiling of Bioactive NanoparticlesSmall, 2008
- Serum or Plasma Samples?Arteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Persistent use of “false” cell linesInternational Journal of Cancer, 2007
- Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequenceEuropean Journal of Cancer, 2006
- Protease-Modulated Cellular Uptake of Quantum DotsNano Letters, 2006
- Recent advances in MMP inhibitor designCancer and Metastasis Reviews, 2006
- Metabolic Mapping of Proteinase Activity with Emphasis on In Situ Zymography of GelatinasesJournal of Histochemistry & Cytochemistry, 2004